Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07141394 · ClinicalTrials.gov registry record · NA
Coordinated Access for Addiction Recovery and Equity in VA Supportive Housing
A NA study, sponsored by VA Office of Research and Development.
- Not yet
- Registry status
- NA
- Development phase
- 7,908
- Enrollment target
NCT07141394: Clinical Trial NA study, sponsored by VA Office of Research and Development.
NCT07141394 is a NA study that has not yet begun recruiting, run by VA Office of Research and Development. The registered enrollment target is 7,908 participants, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (464% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07141394, a NA study, has not yet begun recruiting, sponsored by VA Office of Research and Development.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 7,908 participants
- Enrollment target
Study Summary
The Department of Housing and Urban Development-VA Supportive Housing (HUD-VASH) Program provides subsidized permanent housing with case management to homeless-experienced Veterans (HEVs). Up to 40% of Veterans exit HUD-VASH within two years of attaining housing; substance use disorders (SUDs) are one of the largest causes of returns to homelessness for HEVs. CARE-VASH QUERI proposes to implement and evaluate two evidence-based SUD services - Medications for addiction treatment (MAT) and cognitive behavioral therapy for SUDs (CBT-SUD) - among Veterans in HUD-VASH.
Primary Outcome
* (percent of) Veterans who used Medications for Opioid Use Disorder (MOUD) for OUD, ≥1 prescription * (percent of) Veterans who used MOUD for OUD for 180 days since initial prescription (without a break ≥14 days in supply) * (percent of) Veterans who used Medications for Alcohol Use Disorder (MAUD) for AUD, ≥1 prescription * (percent of) Veterans who used MAUD for AUD for 180 days since initial prescription (without a break ≥14 days in supply)
Interventions
- DRUG Medication for Addiction Treatment (MAT)
- BEHAVIORAL Cognitive Behavioral Therapy for Substance Use Disorders (CBT-SUD)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7,908 participants |
| Start Date | 2026-10-01 |
| Est. Completion | 2030-09-30 |
| Phase | NA |
What is known before NCT07141394 opens enrollment
NCT07141394 is an interventional study that assigns participants to a tested intervention. Its 7,908 participants enrollment target places it among the larger protocols in the corpus, above the 1,403-participant average among 58,714 other NA trials with a reported enrollment target (464% higher).
The record links to 0 conditions, and to 2 interventions - of which Medication for Addiction Treatment (MAT) is the first listed.
NCT07141394 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT07141394 about?
NCT07141394 is a clinical study titled "Coordinated Access for Addiction Recovery and Equity in VA Supportive Housing". The Department of Housing and Urban Development-VA Supportive Housing (HUD-VASH) Program provides subsidized permanent housing with case management to homeless-experienced Veterans (HEVs). Up to 40% of Veterans exit HUD-VASH within two years of attaining housing; substance use disorders (SUDs) are o...
What is the current status of trial NCT07141394?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 7,908 participants. The study started on 2026-10-01. Estimated completion is 2030-09-30.
What interventions are being tested in trial NCT07141394?
The interventions under investigation include: Medication for Addiction Treatment (MAT) (DRUG), Cognitive Behavioral Therapy for Substance Use Disorders (CBT-SUD) (BEHAVIORAL).
Who is sponsoring clinical trial NCT07141394?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT07141394's enrollment target sits among peer trials
7,908 20th of 2000 higher than 1,981 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00539162 · 8,000 participants · NA
Use of the CA 125 Algorithm for the Early Detection of Ovarian Cancer in Low Risk Women
- NCT00898638 · 8,000 participants
Tissue Sample Collection From Patients With Head and Neck Cancer and From Healthy Participants
- NCT02240862 · 8,000 participants
The CREST-2 Registry
- NCT03072927 · 8,000 participants
MILD® Percutaneous Image-Guided Lumbar Decompression: A Medicare Claims Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI